Skip to main content

Table 1 (abstract P113). The characteristics of patients with MAIDS

From: Proceedings of the 27th European Paediatric Rheumatology Congress (PReS 2021)

 

FMF(10)

CAPS(24)

TRAPS(11)

HIDS/MKD(3)

Total (48)

M/F

5/5

10/14

5/6

0/3

20/28

Age (years old)

4,5-38

1,5-9

4,5-21

4-17

1,5-38

The duration of disease (y)

1month-15,5

1,5-44

3 months -21

3,5-15,5

1 month -44

Etanercept

3

-

1

-

4

Аdalimumab

2

-

1

-

3

Tocilizumab

1

2

3

1

7

Сanakinumab

6

18

8

1

33

Аnakinra

1

8

-

1

10